| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |